ANGELINA MAMANOVA: Open Payments
NPI 1932518321 · FRESH MEADOWS, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,359 in 72 payments from 14 companies in 2025. Trend: 2023 $770 · 2024 $2,473 · 2025 $1,359
Food & beverage: $1,359
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 16 | $301 |
| Regeneron Healthcare Solutions, Inc. | 11 | $205 |
| LEO Pharma Inc. | 11 | $179 |
| Incyte Corporation | 11 | $151 |
| Janssen Biotech, Inc. | 5 | $109 |
| PFIZER INC. | 4 | $98 |
| Lilly USA, LLC | 3 | $81 |
| Galderma Laboratories, L.P. | 3 | $61 |
| Novartis Pharmaceuticals Corporation | 2 | $56 |
| UCB, Inc. | 2 | $34 |
Products named: DUPIXENT, ADBRY, RINVOQ, OPZELURA, SKYRIZI, TREMFYA, CIBINQO, NEMLUVIO.
Industry payments across NY — which companies pay providers there.
